661
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation

The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects

, , &
Pages 767-770 | Received 03 Jan 2017, Accepted 26 Apr 2017, Published online: 08 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Theodora Markati, Jessica Duis & Laurent Servais. (2021) Therapies in preclinical and clinical development for Angelman syndrome. Expert Opinion on Investigational Drugs 30:7, pages 709-720.
Read now

Articles from other publishers (11)

Wei-Song Xie, Kiran Shehzadi, Hong-Le Ma & Jian-Hua Liang. (2022) A Potential Strategy for Treatment of Neurodegenerative Disorders by Regulation of Adult Hippocampal Neurogenesis in Human Brain. Current Medicinal Chemistry 29:32, pages 5315-5347.
Crossref
C. G. Jolivalt, M. R. Aghanoori, M. C. Navarro-Diaz, M. M. Han, G. Sanchez, L. Guernsey, D. Quach, K. Johe, P. Fernyhough & N. A. Calcutt. (2022) Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes. Journal of Diabetes Research 2022, pages 1-12.
Crossref
Jessica E. Malberg, René Hen & Torsten M. Madsen. (2021) Adult Neurogenesis and Antidepressant Treatment: The Surprise Finding by Ron Duman and the Field 20 Years Later. Biological Psychiatry 90:2, pages 96-101.
Crossref
Ruth Beckervordersandforth & Chiara Rolando. (2020) Untangling human neurogenesis to understand and counteract brain disorders. Current Opinion in Pharmacology 50, pages 67-73.
Crossref
Michael J. Parnham & Gerd Geisslinger. (2019) Pharmacological plasticity—How do you hit a moving target?. Pharmacology Research & Perspectives 7:6.
Crossref
Corinne G. Jolivalt, Alexandra Marquez, David Quach, Michelle C. Navarro Diaz, Carlos Anaya, Betelhem Kifle, Nabeel Muttalib, Gabriela Sanchez, Lucy Guernsey, Mike Hefferan, Darrel R. Smith, Paul Fernyhough, Karl Johe & Nigel A. Calcutt. (2019) Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189. Diabetes 68:11, pages 2143-2154.
Crossref
Weijian Liu, Yanling Zhou, Wei Zheng, Chengyu Wang, Yanni Zhan, Hanqiu Li, Lijian Chen, Cunyou Zhao & Yuping Ning. (2019) Mediating effect of neurocognition between severity of symptoms and social-occupational function in anxious depression. Journal of Affective Disorders 246, pages 667-673.
Crossref
Anelia A. Y. Kassi, Anil K. Mahavadi, Angelica Clavijo, Daniela Caliz, Stephanie W. Lee, Aminul I. Ahmed, Shoji Yokobori, Zhen Hu, Markus S. Spurlock, Joseph M Wasserman, Karla N. Rivera, Samuel Nodal, Henry R. Powell, Long Di, Rolando Torres, Lai Yee Leung, Andres Mariano Rubiano, Ross M. Bullock & Shyam Gajavelli. (2019) Enduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI. Frontiers in Neurology 9.
Crossref
Yan Liu, Karl Johe, Jiandong Sun, Xiaoning Hao, Yubin Wang, Xiaoning Bi & Michel Baudry. (2019) Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189. Neuropharmacology 144, pages 337-344.
Crossref
Melissa D. Bauman, Cynthia M. Schumann, Erin L. Carlson, Sandra L. Taylor, Edwin Vázquez-Rosa, Coral J. Cintrón-Pérez, Min-Kyoo Shin, Noelle S. Williams & Andrew A. Pieper. (2018) Neuroprotective efficacy of P7C3 compounds in primate hippocampus. Translational Psychiatry 8:1.
Crossref
F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva & F. Drago. (2018) International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacological Reviews 70:3, pages 475-504.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.